Literature DB >> 16280600

Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in Purkinje cells of the cerebellum.

Eduardo Candelario-Jalil1, Helen Slawik, Ingrid Ridelis, Anne Waschbisch, Ravi Shankar Akundi, Michael Hüll, Bernd L Fiebich.   

Abstract

Prostaglandin E2 (PGE2), is a major prostanoid produced by the activity of cyclooxygenases (COX) in response to various physiological and pathological stimuli. PGE2 exerts its effects by activating four specific E-type prostanoid receptors (EP1, EP2, EP3, and EP4). In the present study, we analyzed the expression of the PGE2 receptor EP1 (mRNA and protein) in different regions of the adult rat brain (hippocampus, hypothalamus, striatum, prefrontal cerebral cortex, parietal cortex, brain stem, and cerebellum) using reverse transcription- polymerase chain reaction, Western blotting, and immunohistochemical methods. On a regional basis, levels of EP1 mRNA were the highest in parietal cortex and cerebellum. At the protein level, we found very strong expression of EP1 in cerebellum, as revealed by Western blotting experiments. Furthermore, the present study provides for the first time evidence that the EP1 receptor is highly expressed in the cerebellum, where the Purkinje cells displayed very high immunolabeling of their perikaryon and dendrites, as observed in the immunohistochemical analysis. Results from the present study indicate that the EP1 prostanoid receptor is expressed in specific neuronal populations, which possibly determine the region-specific response to PGE2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280600     DOI: 10.1385/JMN:27:3:303

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Involvement of protein kinase C in prostaglandin E2-induced catecholamine release from cultured bovine adrenal chromaffin cells.

Authors:  M Negishi; S Ito; O Hayaishi
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Characterization of inducible cyclooxygenase in rat brain.

Authors:  C D Breder; D Dewitt; R P Kraig
Journal:  J Comp Neurol       Date:  1995-05-01       Impact factor: 3.215

5.  Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.

Authors:  J W Regan; T J Bailey; D J Pepperl; K L Pierce; A M Bogardus; J E Donello; C E Fairbairn; K M Kedzie; D F Woodward; D W Gil
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

6.  Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors.

Authors:  B L Fiebich; K Biber; K Lieb; D van Calker; M Berger; J Bauer; P J Gebicke-Haerter
Journal:  Glia       Date:  1996-10       Impact factor: 7.452

7.  Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype.

Authors:  L Bastien; N Sawyer; R Grygorczyk; K M Metters; M Adam
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

8.  Co-localization of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey cerebellum.

Authors:  Sibile Pardue; Stanley I Rapoport; Francesca Bosetti
Journal:  Brain Res Mol Brain Res       Date:  2003-08-19

9.  Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor.

Authors:  Kendra N Shaw; Sean Commins; Shane M O'Mara
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

10.  Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.

Authors:  Eduardo Candelario-Jalil; Armando González-Falcón; Michel García-Cabrera; Olga Sonia León; Bernd L Fiebich
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

View more
  20 in total

Review 1.  Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

Authors:  P J Cimino; C Dirk Keene; Richard M Breyer; Kathleen S Montine; Thomas J Montine
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

2.  Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage.

Authors:  Jenna L Leclerc; Andrew S Lampert; Matthew A Diller; Sylvain Doré
Journal:  Eur J Neurosci       Date:  2015-05       Impact factor: 3.386

3.  Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain.

Authors:  Xian Cao; Jeffrey R Peterson; Gang Wang; Josef Anrather; Colin N Young; Mallikarjuna R Guruju; Melissa A Burmeister; Costantino Iadecola; Robin L Davisson
Journal:  Hypertension       Date:  2012-02-27       Impact factor: 10.190

4.  Prostaglandin E2 stimulates estradiol synthesis in the cerebellum postnatally with associated effects on Purkinje neuron dendritic arbor and electrophysiological properties.

Authors:  Shannon L Dean; Christopher L Wright; Jessica F Hoffman; Meina Wang; Bradley E Alger; Margaret M McCarthy
Journal:  Endocrinology       Date:  2012-10-09       Impact factor: 4.736

5.  Rostral Ventrolateral Medulla EP3 Receptor Mediates the Sympathoexcitatory and Pressor Effects of Prostaglandin E2 in Conscious Rats.

Authors:  Samar Rezq; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2016-08-29       Impact factor: 4.030

6.  Apobec-1 increases cyclooxygenase-2 and aggravates injury in oxygen-deprived neurogenic cells and middle cerebral artery occlusion rats.

Authors:  Wei Li; Xin Cheng; Hui-sheng Chen; Zhi-yi He
Journal:  Neurochem Res       Date:  2013-04-23       Impact factor: 3.996

7.  Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.

Authors:  Sofiyan Saleem; Yun Tai Kim; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2009-02-08       Impact factor: 3.478

Review 8.  Emerging roles of PGE2 receptors in models of neurological disease.

Authors:  Katrin Andreasson
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-11       Impact factor: 3.072

9.  Prostaglandin transporter expression in mouse brain during development and in response to hypoxia.

Authors:  S Scafidi; R M Douglas; R Farahani; K J Banasiak; G G Haddad
Journal:  Neuroscience       Date:  2007-04-11       Impact factor: 3.590

10.  The remarkable mechanism of prostaglandin E2 on synaptic plasticity.

Authors:  Yukio Akaneya
Journal:  Gene Regul Syst Bio       Date:  2008-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.